Covid 19 vaccine

J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S.…

The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of…

The company will be enrolling over 1000 subjects across multiple clinical study sites in India for Adaptive Phase I/ II clinical…

Moderna said it will conduct the trial at 87 study locations, all in the U.S

The collaboration is part of the US government’s Operation Warp Speed to accelerate the development of COVID-19 vaccines and…

The study results can facilitate the design of vaccine agents that can elicit a strong neutralising antibody response, say…

The company had earlier received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human…

He added that the administration is already working with companies to equip and outfit manufacturing facilities and acquire raw…

The clinical trials of COVID-19 vaccine produced by Gamalei Institute of Epidemiology and Microbiology started on June 18

Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests